TABLE 3.
Systematic reviews with a quality rating less than 5
Reference, number of studies | Quality score | Focus | Main results |
---|---|---|---|
Rogers and Ostow 2004 (20), n=10 | 4 | EMLA* cream compared with placebo (n=7), iontophoresis (n=2) and amethocaine cream (n=1) for venipuncture pain | EMLA* cream more effective than placebo. Inconclusive evidence regarding comparative efficacy of EMLA* and iontophoresis. No difference found between EMLA* and amethocaine cream. More side effects (erythema, pruritis and tingling) were observed with iontophoresis compared with EMLA*. |
Taddio et al 2002 (21), n=8 | 4 | Lidocaine-prilocaine (EMLA*) cream compared with amethocaine (tetracaine) gel for procedural pain (ie, intravenous cannulation, venipuncture and port-a-cath puncture) | Similar efficacy between lidocaine-prilocaine (60 min) and amethocaine (30 min) when used as labelled. Amethocaine more efficacious than lidocaine-prilocaine when applied for the same duration of time (40 min, 60 min, 2 h). Amethocaine commonly associated with erythema; lidocaine-prilocaine commonly associated with blanching. |
Wild and Espie 2004 (23), n=9 | 4 | Hypnosis in pediatric cancer patients to manage pain associated with medical procedures (ie, BMA, LP). | Inconclusive evidence regarding the efficacy of hypnosis due to methodological constraints of the primary studies (most failed to have appropriate control groups). Adverse events were not reported. |
AstraZeneca Canada Inc. BMA Bone marrow aspiration; LP Lumbar puncture